DCL (PSMA inhibitor) (ACUPA)

DCL (PSMA inhibitor) (ACUPA) is an amino-modified amino acid and a new type of inhibitor that has a highly inhibitory effect on prostate-specific membrane antigen (PSMA). It is introduced into polypeptides through chemical synthesis, thereby changing the properties and activity of the polypeptide. ACUPA-modified amino groups have stability and water solubility, which can enhance the affinity and selectivity of peptides, thereby improving the efficacy and biological activity of peptides. It can also alter the metabolism and distribution of peptides.

msds of DCL (PSMA inhibitor) (ACUPA)